Onward Medical N.V. (ONWD.BR)

EUR 4.23

(0.95%)

Net Debt Summary of Onward Medical N.V.

Onward Medical N.V.'s latest annual net debt in 2023 was -12.89 Million EUR , up 52.91% from previous year.
Onward Medical N.V.'s latest quarterly net debt in 2024 Q2 was -7.23 Million EUR , up 15.14% from previous quarter.
Onward Medical N.V. reported annual net debt of -27.38 Million EUR in 2022, up 63.86% from previous year.
Onward Medical N.V. reported annual net debt of -75.77 Million EUR in 2021, down -312.66% from previous year.
Onward Medical N.V. reported quarterly net debt of -8.53 Million EUR for 2024 Q1, up 33.84% from previous quarter.
Onward Medical N.V. reported quarterly net debt of -12.89 Million EUR for 2023 Q4, up 4.22% from previous quarter.

Annual Net Debt Chart of Onward Medical N.V. (2023 - 2017)

Historical Annual Net Debt of Onward Medical N.V. (2023 - 2017)

Year	Net Debt	Net Debt Growth
2023	-12.89 Million EUR	52.91%
2022	-27.38 Million EUR	63.86%
2021	-75.77 Million EUR	-312.66%
2020	35.63 Million EUR	90.82%
2019	18.67 Million EUR	109.87%
2018	8.89 Million EUR	162.56%
2017	3.38 Million EUR	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-7.23 Million EUR	15.14%
2024 Q1	-8.53 Million EUR	33.84%
2023 Q4	-12.89 Million EUR	4.22%
2023 Q1	-3.42 Million EUR	87.51%
2023 FY	-12.89 Million EUR	52.91%
2023 Q3	-13.46 Million EUR	-358.51%
2023 Q2	-2.93 Million EUR	14.18%
2022 Q3	-27.81 Million EUR	55.76%
2022 Q2	-62.86 Million EUR	0.67%
2022 Q4	-27.38 Million EUR	1.54%
2022 Q1	-63.28 Million EUR	16.49%
2022 FY	-27.38 Million EUR	63.86%
2021 Q4	-75.77 Million EUR	0.62%
2021 FY	-75.77 Million EUR	-312.66%
2021 Q3	-76.25 Million EUR	-275.1%
2021 Q2	43.54 Million EUR	0.3%
2021 Q1	43.41 Million EUR	21.84%
2020 Q4	35.63 Million EUR	0.39%
2020 Q3	35.49 Million EUR	0.0%
2020 Q1	15.12 Million EUR	0.0%
2020 FY	35.63 Million EUR	90.82%
2019 FY	18.67 Million EUR	109.87%
2018 FY	8.89 Million EUR	162.56%
2017 FY	3.38 Million EUR	0.0%

Peer Net Debt Comparison of Onward Medical N.V.

Name	Net Debt	Net Debt Difference
Nicox S.A.	13.89 Million EUR	192.803%
European Medical Solutions	13.93 Million EUR	192.556%
FERMENTALG	4.19 Million EUR	407.513%
argenx SE	-1.83 Billion EUR	99.298%
BioSenic S.A.	28.04 Million EUR	145.978%
Celyad Oncology SA	-6.1 Million EUR	-111.308%
Hyloris Pharmaceuticals SA	-25.11 Million EUR	48.654%
Oxurion NV	10.71 Million EUR	220.392%
PHAXIAM Therapeutics S.A.	-275 Thousand EUR	-4588.727%
Financière de Tubize SA	78.62 Million EUR	116.399%
UCB SA	2.17 Billion EUR	100.592%